Dr. Scoll is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
21 Donald B Dean Drive
Portland, ME 04106Phone+1 207-518-6600Fax+1 207-541-5449
Summary
- I completed my urology training at Temple University Hospital and the Fox Chase Cancer Center in Philadelphia in 2010. Since then, I have practiced in Maine, and I was a founding partner of Fore River Urology.
My areas of clinical interest include treatment of prostate cancer, bladder cancer, kidney cancer, male voiding dysfunction, and complex stone disease. I perform laparoscopic surgery, GreenLight laser prostate surgery (PVP), Rezum prostate thermal therapy, no-scalpel vasectomy, and advanced stone treatments such as percutaneous nephrolithotomy (PCNL).
Education & Training
Temple University HospitalResidency, Urology, 2006 - 2010- Temple University HospitalResidency, Surgery, 2004 - 2006
Lewis Katz School of Medicine at Temple UniversityClass of 2004
Certifications & Licensure
ME State Medical License 2010 - 2026
PA State Medical License 2004 - 2010
American Board of Urology Urology
Awards, Honors, & Recognition
- Emerging Leader Award Lewis Katz School of Medicine at Temple University, 2019
- A. Richard Kendall Award for Excellence in Urology Temple University School of Medicine, 2004
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013-2014
Publications & Presentations
PubMed
- 63 citationsMulti-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.Jamie Messer, John D. Terrell, Michael Herman, Casey K. Ng, Douglas S. Scherr
Urologic Oncology. 2013-08-01 - 66 citationsHigh-Grade Ureteroscopic Biopsy Is Associated with Advanced Pathology of Upper-Tract Urothelial Carcinoma Tumors at Definitive Surgical ResectionThomas Clements, Jamie Messer, John D. Terrell, Michael Herman, Casey K. Ng
Journal of Endourology. 2012-04-05 - 167 citationsUrinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.Jamie Messer, Shahrokh F. Shariat, James C. Brien, Michael Herman, Casey K. Ng
BJU International. 2011-09-01
Press Mentions
2019 Alumni Award RecipientsApril 2nd, 2020
Professional Memberships
- Member
External Links
- Fore River Urologyhttp://www.frurology.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
